<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1243">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05144971</url>
  </required_header>
  <id_info>
    <org_study_id>NB21-SSA-NA-LAY-FDA</org_study_id>
    <nct_id>NCT05144971</nct_id>
  </id_info>
  <brief_title>StatStrip A Glucose/Creatinine Meter System Lay User Study Evaluation</brief_title>
  <official_title>StatStrip A Glucose/Creatinine Meter System Lay User Study Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nova Biomedical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Excellence Medical and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nova Biomedical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to assess the performance of the Nova StatStrip A&#xD;
      Glucose/Creatinine Meter System in the hands of the subject (lay user) and compare the result&#xD;
      to an accepted Glucose/Creatinine reference method in the hands of a trained technician.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To assess the performance of the StatStrip A Glucose/Creatinine assay in the hands of lay&#xD;
      users on capillary whole blood obtained by finger stick and compare with the performance&#xD;
      characteristics to a central laboratory traceable reference method.&#xD;
&#xD;
      To assess the Ease of Use of the StatStrip Glucose / Creatinine Meter System in the hands of&#xD;
      the intended lay users. Lay users will be provided with all package insert sheets, a Quick&#xD;
      Reference Guide and Instructions for Use (IFU) Manual. No training, coaching, or prompting&#xD;
      will be provided to the lay users other than clarifying the protocol.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 28, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Nova StatStrip A Glucose/Creatinine Meter System</measure>
    <time_frame>20 days</time_frame>
    <description>The primary objective of this study is to assess the performance of the Nova StatStrip A Glucose/Creatinine Meter System in the hands of the subject (lay user) and compare the result to an accepted Glucose/Creatinine reference method in the hands of a trained technician.</description>
  </primary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Diabete Mellitus</condition>
  <condition>CKD</condition>
  <condition>ESRD</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Glucose, Creatinine</intervention_name>
    <description>Compare diagnostic tests to reference methods</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A minimum of 150 to a maximum of 200 individual subjects (lay users) will be enrolled.&#xD;
&#xD;
        Subjects included in the study may be healthy, diabetic or having kidney diseases. The&#xD;
        study will be conducted at one study site.&#xD;
&#xD;
        Adult subjects (≥ 18 years old) of both genders will be included in this study.&#xD;
&#xD;
        Potential subjects may be screened prior to testing to assess their baseline&#xD;
        glucose/creatinine levels. The screening may be done by inspecting medical records.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult subjects (≥ 18 years old) with diabetes.&#xD;
&#xD;
          -  Adult subjects (≥ 18 years old) with kidney diseases (CKD, ESRD) and/or in dialysis.&#xD;
&#xD;
          -  Adult subjects (≥ 18 years old) that are healthy.&#xD;
&#xD;
          -  Subjects willing to complete all study procedures.&#xD;
&#xD;
          -  Subjects whose pre-screen glucose or creatinine medical history is deemed of value by&#xD;
             the study site&#xD;
&#xD;
          -  Subjects able to read, write, speak in English.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects unable to consent to participating in the study.&#xD;
&#xD;
          -  Subjects possessing a cognitive disorder or other condition, which, in the opinion of&#xD;
             the investigator, would put the person at risk or seriously compromise the integrity&#xD;
             of the study.&#xD;
&#xD;
          -  Subjects taking prescription anticoagulants (such as Warfarin or Heparin) or has&#xD;
             clotting problems that may prolong bleeding.&#xD;
&#xD;
          -  Subjects having hemophilia or any other bleeding disorder.&#xD;
&#xD;
          -  Subjects having an infection with a blood borne pathogen (e.g. HIV, hepatitis).&#xD;
&#xD;
          -  Subjects working for a medical device or diagnostic company.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jarrid Legere, Bachelor</last_name>
    <phone>781-894-0800</phone>
    <phone_ext>1801</phone_ext>
    <email>jlegere@novabio.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wei Qiu, MD, PhD</last_name>
    <phone>7815306043</phone>
    <phone_ext>1715</phone_ext>
    <email>wqiu@novabio.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Excellence Medical Research</name>
      <address>
        <city>Miami Gardens</city>
        <state>Florida</state>
        <zip>33169</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Martinez</last_name>
      <phone>786-205-8666</phone>
      <email>amartinez@emrclinic.com</email>
    </contact>
    <investigator>
      <last_name>Jeremy Bleicher</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 22, 2021</study_first_submitted>
  <study_first_submitted_qc>November 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2021</study_first_posted>
  <last_update_submitted>November 22, 2021</last_update_submitted>
  <last_update_submitted_qc>November 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>CKD</keyword>
  <keyword>ESRD</keyword>
  <keyword>POCT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

